Is rivaroxaban noninferior to standard warfarin therapy in preventing recurrent PE and DVT?

Journal article

Mark A Graber, Robert Dachs and Jill Endres

American family physician, Vol.87(12), pp.872-873

06/15/2013

PMID: 23939570

View Online

no abstract | AFP Journal Club

Anticoagulants - therapeutic use

Female

Humans

Male

Morpholines - therapeutic use

Pulmonary Embolism - drug therapy

Thiophenes - therapeutic use

Title: Subtitle: Is rivaroxaban noninferior to standard warfarin therapy in preventing recurrent PE and DVT?
Creators: Mark A Graber - University of Iowa Carver College of Medicine, Iowa City, IA, USA. mark-graber@uiowa.edu
Robert Dachs
Jill Endres
Resource Type: Journal article
Publication Details: American family physician, Vol.87(12), pp.872-873
PMID: 23939570
ISSN: 0002-838X
eISSN: 1532-0650
Language: English
Date published: 06/15/2013
Academic Unit: Emergency Medicine; Family and Community Medicine
Record Identifier: 9984297338202771

26 Record Views